A Clinical Trial to Assess the Efficacy and Safety of MK-0653C in Japanese Participants With Hypercholesterolemia (MK-0653C-383)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 309 participants.
Also called NCT02550288
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 309 participants
- Sponsor
- Registry
-
NCT02550288
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Not reported
- Registry status
- Completed
Technical summary
Registry record NCT02550288. Randomized; double masking; primary purpose treatment. Start 2015-09-29 (actual); primary completion 2016-05-30 (actual). Results posted on 2017-06-21.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Clinical Trial to Assess the Efficacy and Safety of MK-0653C in Japanese Participants With Hypercholesterolemia (MK-0653C-383)
- Condition
- Hypercholesterolemia
- Intervention (Drug)
- Ezetimibe 10 mg
- Intervention (Drug)
- Atorvastatin 10 mg
- Intervention (Drug)
- Placebo for Ezetimibe 10 mg tablet
- Intervention (Drug)
- Placebo for Atorvastatin 10 mg capsule
- Intervention (Behavioral)
- Diet control/Daily Exercise
- Lead sponsor
- Organon and Co
Record details
- Record id
cardio:ct-nct02550288- Content hash
2e0b6d54a1b30b4d4e150c5fa615146ad73131886767a96cc4d8c3143bddb37f